Reme-D
About
Develops temperature-resilient molecular diagnostic kits manufactured in Cairo for use where refrigeration and lab infrastructure are limited; products target infectious diseases and plan to expand into oncology and genetic testing.
Founders
Recent News
#108 This week In MENA's Startup Scene! - by Maxim Hamida
This roundup covers more than $150M in announced financing across MENA, with notable deals including Saudi fintech Fina's $75M debt facility, SILQ's $20M structured financing, Labby's $10M investment to build a Syrian super app, and several seed and pre-seed rounds.
Egyptian startups secure $3.5mn as investors favour infrastructure
Egyptian startups Mylerz and Reme-D raised a combined $3.5M, with Mylerz securing over $2M to expand warehousing and last-mile delivery and Reme-D closing a $1.45M pre-Series A to scale molecular diagnostic kit production and exports.
Investment momentum continues in MENA amid conflict
Investment momentum in MENA continued despite regional tensions with notable fund commitments and startup rounds across Saudi Arabia, Egypt and Syria, including SEEDRA Ventures Fund II, Reme-D, FLOATY Studio and Labby.
Cairo’s Diagnostics Bet: How a $1.45 Million Round Signals Where African Healthtech Is Headed
Cairo-based diagnostics startup Reme-D closed a $1.45M pre-Series A led by Anara Impact Capital with participation from Global Innovation Fund and Africa Health Ventures, signaling investor interest in patient, impact-focused diagnostic businesses in Egypt and the region.